Profile of Disability in Leprosy Patients: A Retrospective Study
Downloads
Background: Leprosy is a chronic granulomatous infectious disease caused by Mycobacterium leprae that affects peripheral nerves and skin. The interaction between M. leprae and Schwann cells causes irreversible damage to peripheral nervous tissue afterward disability occurs. Involvement of the major nervous trunks of the extremities can produce sensory-motor deficits. The risk factors are delay in diagnosis, gender, age, type of leprosy, duration of disease, number of affected nerves, leprosy reaction, type of treatment, socioeconomic factors, education, ethnicity, and occupation. Purpose: The aim was to study the profile of leprosy patients with disability who seek treatment in Leprosy Division Dermatovenerology Outpatient Clinic RSUD Dr. Soetomo Surabaya. Methods: This was a descriptive retrospective study of leprosy patients with disability from January 2017 to December 2019. Result: The results of this study obtained a total of 275 leprosy patients with disabilities, which consisted of 76 patients (27.6%) with grade-1 disability and 199 patients (72.4%) with grade-2 disability. The majority were male (73.4%) and aged 25-44 years old (42.2%). Other dominant risk factors were MB type leprosy (92%), duration of disease more than 12 months (52.3%), no leprosy reaction (68%), and had received multidrug therapy (45.5%). Conclusion: Knowledge of disability risk factors can assist in improving management and education to prevent disability in leprosy patients.
Lockwood DNJ. Leprosy. In: Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D, editors. Rook textbook of dermatology. 9th Ed. London: Wiley Blackwell; 2016. p. 28.1-2.
Reyila PV, Betsy A, Riyaz N, Sasidharanpillai S, Sheerjeena PVB, Majitha MP, et al. Clinico epidemiological study of disability due to leprosy at the time of diagnosis among patients attending a tertiary care institution. Indian J Dermatol 2019; 64(2):101-11.
Salgado CG, de Brito AC, Salgado UI, Spencer JS. Leprosy. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al., editors. Fitzpatrick's Dermatology. 9th Edition. New York: McGraw-Hill Education; 2019. p. 2892–924.
Santana EMF, Brito KKG, Leabedal ODCP, Costa MML, Silva MA, et al. Deficiencies and disabilities in leprosy: from the diagnosis to discharge by cure. Rev Eletr Enf 2018; 2:v20a15.
Mangala HC, Jeyaraman M, Chaudari K, Dhorde V, Likhith D. A study on prevalence of deformities in leprosy in a tertiary care hospital at Davangere. J Mycobact Dis 2019; 9: 275.
Bungin C, Toruan VML, Riastiti Y. The correlation between leprosy type and grade of disability in leprosy patients in Samarinda. J Ilmu Kesehat 2019; 8(1):32-6.
Raghavendra BN, Aneesh S, Yarramachu S, Anoop GDS, MuneerM. Clinical pattern of deformities and disabilities in leprosy patients in rural Bangalore – a two year study at tertiary level hospital'. Indian J Dermatol 2017; 3(3):101-9.
Mowla MR, Angkur DM, Hasan Z, Sultana MN, Afrin S, Akhter MS. Leprosy patients with deformities at post-elimination stage: the Bangladesh experience. Skin Health Dis 2020; 1: 1-8.
Daniel SJ, Kumar SK, Babu RA. A prospective observational study of deformities in leprosy in tertiary care center in South India. IP Indian J Clin and Exp Dermatol 2019; 5(1):61-7.
Kumar A, Girdhar A, Girdhar BK, Risk of developing disability in pre and post-multidrug therapy treatment among multibacillary leprosy: Agra MB cohort study. BMJ Open 2012; 2(2):1-74.
Jha SM, Dangol AKS, Shakya S, Jha B. Clinico-bacterial correlation of bacterial index in Hansen's disease. J pathol Nepal 2016; 6(12): 998-1000.
Rathod SP, Jagati A, Chowdhary P. Disabilities in leprosy: an open, retrospective analyses of institutional records. An Bras Dermatol 2020; 95:52- 6.
Malaviya GN. Deformity and disability prevention. In: Kumar B, Kar HK, editors. IAL textbook of leprosy. New Delhi: Jaypee Brothers Medical Publisher; 2017. p. 542-61.
Santos VS, Matos AMS, Oliveira LSA, Lemos MD, Gurgel RQ, Reis FP, et al. Clinical variables associated with disability in leprosy cases in Northeast Brazil. J Infect Dev Ctries 2015; 9(3):232-8.
Sales AN, Campos DP, Hacker MA, Nery JAC, Dupre NC, Rangel E., et al. Progression of leprosy disability after discharge: is multidrug therapy enough? Trop Med Int Health 2013; 18(9): 1145-53.
Raffe SF, Thapa M, Khadge S, Tamang K, Hagge D, Lockwood DNJ. Diagnosis and treatment of leprosy reactions in integrated services – the patient's perspective in Nepal. PLOS Negl Trop Dis 2013; 7(3): e2089.
Lockwood DNJ, Saunderson PR. Nerve damage in leprosy: a continuing challenge to scientists, clinicians and service providers. Int Health 2012; 4(2):77-85.
Alinda MD, Geani S, Agusni RI, Kusumaputra BH, Reza NR, Prakoeswa CRS, et al. Diagnosis and management of leprosy. Berkala Ilmu Kesehatan Kulit Kelamin 2020; 32(2):149-57.
Prakoeswa CRS, Lubis RS, Anum Q, Argentina F, Menaldi SL, Gunawan H, et al. Epidemiology of leprosy in Indonesia: a retrospective study. Berkala Ilmu Kesehatan Kulit Kelamin 2022; 34(1):29-35.
Haefner K, Walther F, Chichava OA, Ariza L, Alencar CH, de Alencar MDJF, et al. High occurrence of disabilities caused by leprosy: census from a hyperendemic area in Brazil's Savannah region. Lepr Rev 2017; 88(4):520–32.
Copyright (c) 2022 Berkala Ilmu Kesehatan Kulit dan Kelamin
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
